未登录

J

Justus B. Cohen

university of pittsburgh

H指数:43

被引数:5,769

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Durable tissue-specific transgene expression in newborn mice following intraperitoneal delivery of non-cytotoxic herpes simplex virus-based vectors

经腹腔给药的非细胞毒性单纯疱疹病毒载体在新生小鼠中实现持久的组织特异性转基因表达

Molecular Therapy Methods & Clinical Development

IF4.7

2025-08-200

OAAI

U1 small nuclear RNA-promoted exon selection requires a minimal distance between the position of U1 binding and the 3' splice site across the exon

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-2929

OAAI

Treatment of glioblastoma with current oHSV variants reveals differences in efficacy and immune cell recruitment

MOLECULAR THERAPY-ONCOLYTICS

IF0

2021-09-014

OAAI

Cellular Antisilencing Elements Support Transgene Expression from Herpes Simplex Virus Vectors in the Absence of Immediate Early Gene Expression

JOURNAL OF VIROLOGY

IF3.8

2018-09-0113

OA

Engineered HSV vector achieves safe long-term transgene expression in the central nervous system

SCIENTIFIC REPORTS

IF3.9

2017-05-0429

OAAI

Syncytial Mutations Do Not Impair the Specificity of Entry and Spread of a Glycoprotein D Receptor-Retargeted Herpes Simplex Virus

JOURNAL OF VIROLOGY

IF3.8

2016-12-1510

OAAI

Retargeting of herpes simplex virus (HSV) vectors

CURRENT OPINION IN VIROLOGY

IF5.1

2016-12-0135

OAAI

HSV Vectors Retargeted for Infection of TrkA Receptor-Bearing, Pain-Sensing C-Fibers

MOLECULAR THERAPY

IF12

2016-05-010

OAAI

Replication-Defective HSV Vector Development for Targeted Gene Delivery

MOLECULAR THERAPY

IF12

2016-05-010

OAAI

HERPES SIMPLEX VIRUS (HSV) VECTOR-MEDIATED GENE DELIVERY OF PORELESS TRPV1 CHANNELS OR PROTEIN PHOSPHATE 1α (PP1α) REDUCES BLADDER OVERACTIVITY AND NOCICEPTION IN RAT MODEL OF CYSTITIS INDUCED BY HYDROGEN PEROXIDE

JOURNAL OF UROLOGY

IF6.8

2016-04-010

OA

Arming a tumor targeted oncolytic herpes simplex sirus type 1 with matrix metalloproteinase 9 for enhanced vector distribution and killing activity

CANCER RESEARCH

IF16.6

2015-08-010

PRE

CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells

SCIENTIFIC REPORTS

IF3.9

2015-07-09314

OAAI

HSV Vector-Mediated Expression of a Novel Drug Activated Pain Signalling Therapeutic Abrogates Pain

MOLECULAR THERAPY

IF12

2015-05-010

OAAI

Benign Herpes Simplex Virus Vector Design for Efficient Delivery of Large or Multiple Transgenes To a Diversity of Cells

MOLECULAR THERAPY

IF12

2015-05-010

OAAI

HSV Vector Development for Targeted Gene Delivery

MOLECULAR THERAPY

IF12

2015-05-010

OAAI

HERPES SIMPLEX VIRUS (HSV) VECTOR-MEDIATED GENE DELIVERY OF PROTEIN PHOSPHATASE 1α REDUCES BLADDER OVERACTIVITY AND

JOURNAL OF UROLOGY

IF6.8

2015-04-010

PREAI

Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2015-03-1663

OAAI

Use of miRNA Response Sequences to Block Off-target Replication and Increase the Safety of an Unattenuated, Glioblastoma-targeted Oncolytic HSV

MOLECULAR THERAPY

IF12

2015-01-0178

OAAI

HIGHLY SELECTIVE HSV VIROTHERAPY FOR TREATMENT OF GLIOBLASTOMA

IF13.4

2014-11-030

OAAI

Highly selective HSV virotherapy for glioblastoma

CANCER RESEARCH

IF16.6

2014-10-010

PRE